Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tilray Brands Inc (NQ: TLRY )

1.310 +0.020 (+1.55%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tilray Brands Inc

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stocks Mixed After Job Openings, Consumer Data
Stocks are mixed midday, as the Federal Reserve's two-day policy meeting gets underway, with plenty of earnings and economic data for Wall Street to unpack in the meantime. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
What's Going On With Canopy Growth Stock?
Canopy Growth shares are trading higher Tuesday after cannabis-peer Tilray Brands reported better-than-expected quarterly results. Here's a look at what's going on: 
Via Benzinga
PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Tilray Stock Is Trading Higher Tuesday: Here's Why
Tilray Brands Inc (NASDAQ:TLRY) shares are trading higher Tuesday after the company reported better-than-expected financial results for the fourth quarter. 
Via Benzinga
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting. 
Via Benzinga
Topics Economy
Exposures Interest Rates
What's Going On With Tilray Brands Stock Friday?
Tilray is anticipated to release 2024 fiscal year and fourth quarter earnings on Monday after the market closes. 
Via Benzinga
'Tilray Should Be A Long-Term Holding In Any Global Portfolio Of Cannabis Stocks,' Says Analyst
Via Benzinga
Topics Cannabis
Exposures Cannabis
Nasdaq, S&P Futures Rise As Microsoft, AMD Earnings Take Spotlight: Will Fed Provide 'Turbo Boost' For Market? Analyst Weighs In
Wall Street is likely to tenaciously hold onto the slender optimism ahead of a slew of earnings from notable companies and the Federal Reserve’s two-day rate-setting meeting that gets underway on... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Tilray Brands (TLRY) Q4 2024 Earnings Call Transcript
TLRY earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Hempcrete Project Gets $6.2M EPA Grant To Develop Eco-Friendly Construction Materials
EPA grants $6.2M to Hemp Building Institute to boost hempcrete use in construction, aligning with Biden's climate goals. Read now! 
Via Benzinga
TLRY Stock Earnings: Tilray Brands Beats EPS, Beats Revenue for Q4 2024
TLRY stock results show that Tilray Brands beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
Tilray Q4 Earnings: Revenue, EPS Beat As Cannabis, Beverages, Wellness Converge On A Global Scale, Driving 'Remarkable Growth'
Tilray Brands reports fourth-quarter financial results for fiscal year 2024 after the market close on Monday. Here's a look at the key metrics from the quarter. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For July 29, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Brands Reports Record Financial Results, Achieves 26% Net Revenue Growth
From Tilray Brands, Inc.
Via GlobeNewswire
Why Is Beamr Imaging (BMR) Stock Moving Today?
Beamr Imaging stock is down on Monday after an early morning rally for BMR shares with an update on its video optimization. 
Via InvestorPlace
HSBC Just Slashed Its Price Target on Tesla (TSLA) Stock to New Street Low
Tesla stock is up on Monday even as TSLA shares get hit with a lowered price target to $118 from HSBC analysts alongside a reduce rating. 
Via InvestorPlace
TLRY Stock: Tilray’s Aphria RX Receives Cannabis Trading License in Germany
Tilray stock is up on Monday after investors in TLRY learned of the company getting a new cannabis trading license in Germany. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
What's Going On With Tilray Stock Monday?
Tilray's Aphria has received a trading license that will allow it to sell and distribute a broad range of medical cannabis products to pharmacies, hospitals and medical wholesalers throughout Germany. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
German Cannabis Producer Demecan Can Grow Unlimited Amounts Of Marijuana, Sees Strong Revenue Growth
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Can Sell And Distribute Medical Marijuana To German Pharmacies, Hospitals And More
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Monday that Aphria RX GmbH has received a trading license. The new permit would allow the Canadian cannabis giant to sell and distribute a... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
US Stocks Look To Extend Gains Ahead Of Key Tech Earnings, FOMC Meeting: Analyst Says This 'Could Serve As A Fundamental Catalyst For Small And Mid-Cap'
Index futures trading indicates cautious optimism as traders anticipate a busy week, with a slew of earnings reports, the two-day Federal Open Market Committee meeting starting Tuesday, and Friday’s... 
Via Benzinga
Tilray’s Aphria RX Receives Cannabis Trading License in Germany, Significantly Expanding Commercial Growth Opportunities
From Tilray Brands, Inc.
Via GlobeNewswire
Canadian Cannabis LPs Out-Performed American MSOs Again This Week
The largest cannabis companies in Canada and the U.S. are ramping up investments in, and sales to, Germany, the largest medical cannabis market in Europe, given the fact that only a few local companies... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Bullish Friday For Marijuana Stocks - GreenGro Technologies, Leafbuyer Techs Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From July 24, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Gets Second Approval For Medical Marijuana Extract In Portugal
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Medical Granted Approval to Introduce Third Medical Cannabis Product in Portugal
Tilray's Solução Oral THC10:CBD10 Medical Cannabis Extract is Now Approved for Medical Use in Portugal 
From Tilray Brands, Inc.
Via GlobeNewswire
Get Your Money Out of These 3 Cannabis Stocks by 2025
These three cannabis stocks may tumble in 2025 despite projected industry growth. Here is what experts projected about their performance. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Cannabis Stocks React To Biden Announcement: Monday's Closing Market Moves
The cannabis sector witnessed significant movement today, with varied performances across key stocks and ETFs following President Joe Biden’s Sunday announcement that he will not seek re-election. 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
Marijuana Stock Movers For July 22, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.